1Hollenberg NK, Fisher ND, Price DA. Pathways for Angiotensin Ⅱ generation in intact human tissue: evidence from comparative pharmacological interruption of the renin system. Hypertension, 1998.32 (3) : 387-392.
2Lanas F, Garbs E, Eggers G, et al. Comparison of the effects of digoxin or enalapril in the treatment of heart failure due to mitral insufficiency. Rev Med Chil,.1998,126(3):251-257.
3Pitt B, Segal R, Martinez FA, et al. ChAng PI Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELIRTE). Lancet, 1997, 349:9054,747-752.
5Obata T, Yamanaka Y. Effect of OH scavenging action by non- SH- containing Angiotensin converting enzyme inhibitor imidaprilat using microdialysis. J Physiol Paris, 1998;92(1) : 1-46.
6Gelpi RJ, Morales C, Rodrguez M, et al. Effect of enalaprilat on postischemic systolic and diastolic dysfunction (sturmed myocardium) on the isolated rabbit heart. Medicina (B Aires), 1998,58(1) :22-28.
7Jugdutt BI, Humen DP. Limitation of left ventrlcular hypertrophy and dysfunmction by ACE inhibition after anterior Q - wave myocardial infaretlon. Cardiology,1998,89(4) :283-390.
8Zuanetti G, Latini R, Maggioni AP, et al. Tognoni G ffect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction: data from the GISSI - 3 study. Circulation, 1997,96(12) :4239-4245.
9Hirschl MM, Wagner A, Gwechenberger M, et al. Attenuation of thrombolysis - induced increase of plasminogen activator inhibitor- lby intraveraous enalaprilat. Thromb Haemost, 1998; 79:1140- 1143.
10Ohtani S,Fujiwara H,Hasegawa K,et al. Up- regulated expression of angiotensin II type 1 receptor gene in human pathologic hearts. J Card Fail, 1997,3(4):303-310.
